A Study to Test Different Doses of BI 1569912 in People With Depression

NCT06558344 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: BI 1569912
DRUG: Placebo matching BI 1569912

Sponsor

Boehringer Ingelheim